Carfilzomib, Lenalidomide, and Dexamethasone for Newly Diagnosed Multiple Myeloma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Leukemia and Lymphoma
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy and safety of carfilzomib-lenalidomide-dexamethasone in newly diagnosed multiple myeloma: pooled analysis of four single-arm studies
Leukemia and Lymphoma 2022 May 12;[EPub Ahead of Print], O Landgren, D Kazandjian, M Roussel, J Jasielec, D Dytfeld, A Anderson, TA Kervin, K Iskander, I McFadden, AJ JakubowiakFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.